BAMI. The Effect of Intracoronary Reinfusion of Bone Marrow-derived Mononuclear Cells(BM-MNC) on All Cause Mortality in Acute Myocardial Infarction

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 375 participants.

Also called NCT01569178

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 375 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01569178
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Belgium, Czechia, Denmark, Finland, Germany, Italy, Netherlands, Spain, Switzerland, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01569178. Randomized; no masking; primary purpose treatment. Start 2013-09 (registry gives no type); primary completion 2019-11-27 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
BAMI. The Effect of Intracoronary Reinfusion of Bone Marrow-derived Mononuclear Cells(BM-MNC) on All Cause Mortality in Acute Myocardial Infarction
Acronym
BAMI
Condition
Death
Intervention (Procedure)
Bone Marrow aspiration and intracoronary reinfusion
Lead sponsor
Queen Mary University of London (class: other)

Record details

Record id
cardio:ct-nct01569178
Content hash
7e6b3684e17937476826afc7b3c4738ec9603db4556cbea3c638ac559aa7a3d5